Chinese Brokers Performance: A- and H-shares of Chinese brokers rose by an average of 4% and 8% respectively, outperforming the CSI 300 Index and HSI by 3 and 7 percentage points, as reported by JPMorgan.
Future Expectations: JPMorgan anticipates that brokers with high beta, such as EAST MONEY and CMSC, may continue to outperform their peers if the current positive sentiment persists.
Top Stock Recommendation: JPMorgan's top pick in the industry is CICC, highlighting its high beta value and advantages from strong IPO flows in Hong Kong, along with potential easing of capital restrictions.
Short Selling Insights: The report includes short selling data, indicating significant short selling activity for both CICC and CMSC, with respective ratios of 13.102% and 9.757%.
Wall Street analysts forecast 03908 stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for 03908 is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
Wall Street analysts forecast 03908 stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for 03908 is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
0 Hold
0 Sell
Current: 21.660
Low
Averages
High
Current: 21.660
Low
Averages
High
JPMorgan
JPMorgan
maintain
$21.2
Al Analysis
2025-12-19
Reason
JPMorgan
JPMorgan
Price Target
$21.2
Al Analysis
2025-12-19
maintain
Reason
The analyst rating from JPMorgan for CICC (03908.HK) is based on the anticipated arbitrage activities resulting from the proposed merger of DONGXING SECURITIES and CINDA SECURITIES. JPMorgan expects that CICC's H-shares may outperform its A-shares in the short term due to this merger activity. Additionally, the broker noted that CICC's H-shares are estimated to outperform its peers and continue to be a top pick among Chinese brokers, leading to an Overweight rating and a target price of $21.2.
BofA Securities
BofA Securities
maintain
$26.9
2025-12-18
Reason
BofA Securities
BofA Securities
Price Target
$26.9
2025-12-18
maintain
Reason
The analyst rating for CICC was reiterated as "Buy" for its H-shares due to the anticipated positive impact of its planned acquisition of DONGXING SECURITIES and CINDA SECURITIES. BofA Securities noted that upon completion of the acquisitions, CICC's ranking in terms of revenue, net profit, net assets, and net capital is expected to improve significantly, moving from 6th-11th place to 3rd-6th place. This potential growth in ranking and financial metrics supports the positive outlook on CICC's H-shares, while the rating for its A-shares was kept at "Neutral" due to relatively higher valuation requirements.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for 03908
Unlock Now
Morgan Stanley
Overweight
maintain
$28.9
2025-12-18
Reason
Morgan Stanley
Price Target
$28.9
2025-12-18
maintain
Overweight
Reason
The analyst rating from Morgan Stanley is an Overweight rating on CICC (03908.HK) due to the expected upside potential from synergies resulting from the share-swap merger and the limited dilution impact on net asset per share, estimated to be around 9%. Additionally, the management's confidence in rapid integration and the potential for net capital to double post-merger further supports this positive outlook. The target price was set at HKD28.9.
Morgan Stanley
Morgan Stanley
initiated
$28.9
2025-12-18
Reason
Morgan Stanley
Morgan Stanley
Price Target
$28.9
2025-12-18
initiated
Reason
The analyst rating of Overweight for CICC by Morgan Stanley is based on the expectation that the announced stock-swap mergers with Dongxing Securities and Cinda Securities will generate significant synergies. These synergies are anticipated to strengthen CICC's capital base, expand its customer system, and allow for a relatively swift integration process, all while having a limited dilution impact on CICC's H-share shareholders. Additionally, the report predicts a rise in share price within the next 30 days, with an estimated probability of approximately 70-80%.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
